The story of our full-service diagnostics laboratory begins with you.
Whether you’re just embarking on your path to wellness or you’ve been helping families navigate cancer journeys for decades, we’re right beside you—illuminating every option on the road ahead.
CAP 8662247
CLIA 14D2037930
NYSDoh (8512)
With over five decades of combined experience, our expert pathologists and scientists provide cutting-edge testing and diagnostic resources from our state-of-the-art CAP-accredited, CLIA-certified molecular diagnostic laboratory. Whether we’re partnering with oncology practices and hospitals to create strong testing programs and streamlined billing, empowering biopharma to develop precise, effective treatments, or inspiring patients to reclaim their autonomy, our mission is simple: to make the complex clear for everyone. To find the light. To share it.
Services
Our provider portal, GPIS, will give you access to your patients’ lab tests 24/7 from any computer connected to the internet. GPIS can be fully integrated with any platform, workflow or EMR. In addition to our full-service global services, we also offer several opportunities for our clients to participate in the diagnostic process and realize additional revenue through our tech-only arrangements. Through GPIS pathologists can access high-quality images and data in real-time, allowing them to make accurate interpretations of every case from any location.
Innovation
As a group of physician scientists, we are committed to continuously researching and incorporating the latest technologies into our diagnostic workflow. Our scientists work rigorously to develop new molecular tests to ensure that our pathologists have the most accurate data at their disposal at all times. By having an in-house diagnostic team, billing department, and customer service staff, we can deliver fast TATs and respond to your needs quickly and efficiently, providing you with expert consultation and data as soon as it’s available. GoPath also welcomes collaboration inquires. Please contact us for additional information.
Education
Furthering education has always been part of GoPath’s mission. We are strong believers in providing patients with the most beneficial knowledge of their diagnosis and prognosis. We also strive to provide free education on topics that are most relevant to our clients through lectures, webinars, and a live case blog.
2011
2011
Dr. Jim Lu starts an educational web series, GoPathDx.com, to help connect pathology with molecular science
Experiential graphic design is the application of communication skills to the built environment.
2012
2012
GoPath Laboratories LLC was established
2012
2012
The Company moved into an 8,000 sqft headquarters in Buffalo Grove, IL, featuring a state-of-the-art laboratory
2016
2016
Developed a comprehensive suite of services to position itself as a full-spectrum diagnostic partner, providing solutions from anatomic pathology to molecular diagnostics and everything in between
2021
2021
A Partnership with NorthShore university was formed
2021
2021
The hereditary germline panel, ProstateNow, was launched
2022
2022
The FDA-cleared CGP test, OncoTarget 500, was introduced
2022
2022
Relocated headquarters to a newly renovated 30,000 sq. ft. facility and established a state-of-the-art laboratory
2022
2022
When GoPath set out to enhance its capabilities, improve accuracy, and increase productivity, they realized there was no single end-to-end solution for labs ready for digitization. To meet that need, GoPath created DigitCells
Established a Strategic Collaboration with Nucleai to provide integrated AI-powered digital pathology solutions for clinical research and diagnostic applications
2024
2024
Biopharma division was strengthened to become a central lab, offering comprehensive solutions for all biopharmaceutical development needs
2024
2024
Launched OncoCore™, a 32-gene NGS panel for targeted DNA and RNA sequencing
2025
2025
GoPath announces the launch of DiabetesNow, a comprehensive genetic panel developed to assist with the diagnosis, classification, and management of diabetes.